Comparison of Tele-Critical Care Versus Usual Care On ICU Performance (TELESCOPE)
TELESCOPE
1 other identifier
interventional
19,360
1 country
1
Brief Summary
TELESCOPE will be a cluster randomized clinical trial to ascertain whether the use of an intervention including multidisciplinary round with a board certified physician through tele-critical care and periodic meetings to discuss strategies to improve quality indicators can reduce ICU length of stay of patients admitted to intensive care units (ICUs).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 10, 2019
CompletedFirst Posted
Study publicly available on registry
April 19, 2019
CompletedStudy Start
First participant enrolled
August 5, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 7, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedSeptember 28, 2021
August 1, 2021
1.7 years
April 10, 2019
September 23, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Intensive Care Unit Length of Stay
Time until discharge from the intensive care unit
From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days
Secondary Outcomes (10)
In-Hospital Mortality
From date of randomization until the date of hospital discharge or death, whichever comes first, assessed up to 90 days
Standardized Resource Use
From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days
Standardized Mortality Rate
From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days
Incidence Density of Central Line-Associated Bloodstream Infection (CLABSI)
From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days
Incidence Density of Ventilator-Associated Pneumonia (VAP)
From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days
- +5 more secondary outcomes
Other Outcomes (9)
Rate of Patients with Head of the Bed Elevated
From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days
Incidence of Early Reintubation
From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days
Incidence of Accidental Extubation
From date of randomization until the date of ICU discharge or death, whichever comes first, assessed up to 90 days
- +6 more other outcomes
Study Arms (2)
Tele-Critical Care
EXPERIMENTALTele-Critical Care + Audit \& Feedback.
Usual Care
NO INTERVENTIONUsual Care.
Interventions
Daily multidisciplinary rounds with a board certified physician through tele-critical care focusing on: 1) diagnosis; 2) active problems; and 3) therapeutic goals. In addition, the management of health care quality indicators will be conducted by a specially trained (Science of Improvement) board-certified intensive care physician.
Eligibility Criteria
You may qualify if:
- Intensive care units from public hospitals and with at least eight beds
- Intensive care units with physician and nurses available 24 hours a day
You may not qualify if:
- Intensive care units with structured multidisciplinary round more than three times a week based in a formal instrument
- Intensive care units already doing audit \& feedback
- Dedicated coronary care units/cardiac intensive care units or other specialized units
- Step-down units
- Adult patients (\> 18 years old)
- Admitted after the beginning of the study
- Admission for other reasons than medical (e.g., judicial cause)
- Previously included in TELESCOPE (for the primary outcome analysis)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Israelita Albert Einstein
São Paulo, 05652-900, Brazil
Related Publications (3)
Pereira AJ, Noritomi DT, Dos Santos MC, Correa TD, Ferraz LJR, Schettino GPP, Cordioli E, Morbeck RA, Morais LC, Salluh JIF, Azevedo LCP, Biondi RS, Rosa RG, Cavalcanti AB, Berwanger O, Serpa Neto A, Ranzani OT. Effect of Tele-ICU on Clinical Outcomes of Critically Ill Patients: The TELESCOPE Randomized Clinical Trial. JAMA. 2024 Dec 3;332(21):1798-1807. doi: 10.1001/jama.2024.20651.
PMID: 39382244DERIVEDRanzani O, Pereira AJ, Santos MCD, Correa TD, Ferraz LJR, Cordioli E, Morbeck RA, Berwanger O, Morais LC, Schettino G, Cavalcanti AB, Rosa RG, Biondi RS, Salluh JIF, Azevedo LCP, Serpa Neto A, Noritomi DT. Statistical analysis of a cluster-randomized clinical trial on adult general intensive care units in Brazil: TELE-critical care verSus usual Care On ICU PErformance (TELESCOPE) trial. Rev Bras Ter Intensiva. 2022 Jan-Mar;34(1):87-95. doi: 10.5935/0103-507x.20220003-pt.
PMID: 35766658DERIVEDNoritomi DT, Ranzani OT, Ferraz LJR, Dos Santos MC, Cordioli E, Albaladejo R, Serpa Neto A, Correa TD, Berwanger O, de Morais LC, Schettino G, Cavalcanti AB, Rosa RG, Biondi RS, Salluh JI, Azevedo LCP, Pereira AJ; TELESCOPE Trial Investigators. TELE-critical Care verSus usual Care On ICU PErformance (TELESCOPE): protocol for a cluster-randomised clinical trial on adult general ICUs in Brazil. BMJ Open. 2021 Jun 21;11(6):e042302. doi: 10.1136/bmjopen-2020-042302.
PMID: 34155070DERIVED
Study Officials
- STUDY DIRECTOR
Adriano J Pereira, MD PhD
Hospital Israelita Albert Einstein
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 10, 2019
First Posted
April 19, 2019
Study Start
August 5, 2019
Primary Completion
April 7, 2021
Study Completion
December 31, 2021
Last Updated
September 28, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR, ANALYTIC CODE
- Time Frame
- After two years of the first publication
- Access Criteria
- Data will be acessed through an online repository protected with password and for secondary analyses according to pre-specified plans.
Data sharing open to researchers not members of the study after two years of the publication of the main study